| Troy Dillon Cooper, | |
|
344 E 100 S Ste 301, Salt Lake City, UT 84111-1727 | |
| (801) 355-4257 | |
| Not Available |
| Full Name | Troy Dillon Cooper |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 344 E 100 S Ste 301, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174830954 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 8377654-3502 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Troy Dillon Cooper, 314 S 700 E Apt 1, Salt Lake City, UT 84102-2156 Ph: (435) 770-0921 | Troy Dillon Cooper, 344 E 100 S Ste 301, Salt Lake City, UT 84111-1727 Ph: (801) 355-4257 |
News Archive
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead's investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.
Unless Ebola control measures in West Africa are enhanced quickly, experts from the World Health Organization and Imperial College, London, predict numbers will continue to climb exponentially, and more than 20,000 people will have been infected by early November, according to a new article in the New England Journal of Medicine released six months after WHO was first notified of the outbreak in West Africa.
People who live in urban areas are more likely to develop late-stage cancer than those who live in suburban and rural areas. That is the conclusion of a new study published in the June 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b.
A new study, released as a preprint on the medRxiv* server, offers some insights into what may be expected in this field, how common it is, how it presents, and how it compares with chronic sequelae of other respiratory viruses.
› Verified 7 days ago
Mr. Glen Ray Lambert, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1361 Rebecca Cir, Salt Lake City, UT 84117 Phone: 801-272-7742 Fax: 801-322-2831 | |
Mr. Mark Lynn Duke, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 132 South State, Suite 200, Salt Lake City, UT 84111 Phone: 801-240-3556 | |
Kristine Louise Nelson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Va Slc, 500 Foothill Blvd, Salt Lake City, UT 84148 Phone: 801-582-1565 | |
Dr. Joel L Millard, DSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 150 E 700 S, Salt Lake City, UT 84111 Phone: 801-364-8080 Fax: 801-364-8098 | |
Matthew Kael Nisson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
Michael Keith Slade, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2872 S Highland Dr, Salt Lake City, UT 84106 Phone: 801-485-8051 | |
Laura Marie Baumgart, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1390 S 1100 E Ste 204, Salt Lake City, UT 84105 Phone: 734-306-1279 |